{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:19:38Z","timestamp":1787109578761,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["FNS 320030-172991"],"award-info":[{"award-number":["FNS 320030-172991"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.euros.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T13:01:15Z","timestamp":1664802075000},"page":"55-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intravesical Ty21a Treatment of Non\u2013muscle-invasive Bladder Cancer Shows a Good Safety Profile"],"prefix":"10.1016","volume":"45","author":[{"given":"Ilaria","family":"Lucca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Derr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Cesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Bohner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Crettenand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rodrigues-Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dartiguenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Masnada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Texeira-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulayman","family":"Benmerzoug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Domingos-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Jichlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Nardelli-Haefliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2022.09.004_b0005","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2022.09.004_b0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","article-title":"The role of bacillus Calmette-Guerin in the treatment of non\u2013muscle-invasive bladder cancer","volume":"57","author":"Gontero","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.09.004_b0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.09.004_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.eururo.2014.11.031","article-title":"Therapeutic options in high-risk non\u2013muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Guerin","volume":"67","author":"Mostafid","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.09.004_b0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterization of galE mutant Ty 21a of Salmonella typhi. A candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.euros.2022.09.004_b0030","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against typhoid fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.euros.2022.09.004_b0035","doi-asserted-by":"crossref","first-page":"e1265720","DOI":"10.1080\/2162402X.2016.1265720","article-title":"Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer","volume":"6","author":"Domingos-Pereira","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.euros.2022.09.004_b0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/2326-6066.CIR-18-0671","article-title":"Intravesical Ty21a vaccine promotes dendritic cells and T cell-mediated tumor regression in the MB49 bladder cancer model","volume":"7","author":"Domingos-Pereira","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.euros.2022.09.004_b0045","first-page":"1017","article-title":"Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro","volume":"62","author":"Summerhayes","year":"1979","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euros.2022.09.004_b0050","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/1097-0142(19870801)60:3<326::AID-CNCR2820600309>3.0.CO;2-5","article-title":"Toxicity of intravesical BCG and its management in patients with superficial bladder tumors","volume":"60","author":"Orihuela","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2022.09.004_b0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1442-2042.1996.tb00490.x","article-title":"Local toxicity patterns associated with intravesical bacillus Calmette-Guerin: a Southwest Oncology Group study","volume":"3","author":"Berry","year":"1996","journal-title":"Int J Urol"},{"key":"10.1016\/j.euros.2022.09.004_b0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0302-2838(03)00357-9","article-title":"EORTC Genito-Urinary Tract Cancer Group. Maintenance bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial","volume":"44","author":"van der Meijden","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.09.004_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","article-title":"Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them","volume":"149","author":"Koch","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.euros.2022.09.004_b0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/infdis\/136.6.717","article-title":"Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine","volume":"136","author":"Gilman","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.euros.2022.09.004_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fcimb.2016.00014","article-title":"The basics of bacteriuria: strategies of microbes for persistence in urine","volume":"6","author":"Ipe","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.euros.2022.09.004_b0080","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/jcm.33.7.1791-1792.1995","article-title":"Significance of Salmonella typhi bacteriuria","volume":"33","author":"Mathai","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.euros.2022.09.004_b0085","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0022-5347(05)66410-5","article-title":"The fate of bacillus Calmette-Guerin after intravesical instillation","volume":"165","author":"Durek","year":"2001","journal-title":"J Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168322019048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168322019048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:07:43Z","timestamp":1762978063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168322019048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":17,"alternative-id":["S2666168322019048"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2022.09.004","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravesical Ty21a Treatment of Non\u2013muscle-invasive Bladder Cancer Shows a Good Safety Profile","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}